Collegium Pharmaceutical, Inc.

NASDAQ:COLL

Drug Manufacturers - Specialty & Generic

Healthcare
$25.93 -0.71%

-$0.24 today

Market cap
$805.79M
Beta
0.75
P/E (TTM)
14.3
EPS (TTM)
$2.34
52W Low $29.19High $50.79

Volume 0.49M

Average 0.50M

COLL Cost of Revenue

Direct costs of producing the goods and services sold, such as materials, manufacturing, and service delivery.

Collegium Pharmaceutical, Inc.NASDAQ: COLL

Cost of Revenue · Q1 FY2026 · quarter ended Mar 2026

Cost of revenue dips below year-ago levels

Q1 FY2026 cost of revenue of $76.27M fell 5.2% year over year, behind the +11.4% change in trailing-twelve-month cost of revenue. Sequentially, it fell 1.0% from the prior quarter. Over 3 fiscal years it compounded at +7.6% a year.

Context

  • Cost of revenue amounted to 40.7% of revenue in FY2025, up 0.4 pp from a year earlier.
  • Cost of revenue increased in 2 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from -5.2% toward the trailing-twelve-month pace of +11.4%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
$76.27M-1.0% QoQ
Last fiscal yearDec 2025
$317.31M+24.9% YoY
LTMMar 2026
$313.15M+11.4% YoY
Cost of Revenue past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-5.2%——
1 year+24.9%——
3-year CAGR+7.6%——
5-year CAGR——
10-year CAGR——

Cost of Revenue history

USD · from the income statement

Latest · FY2025
317.31M USD
Year-over-year change
+24.9%
4-year CAGR
+25.9%

Cost of Revenue vs competitors

How COLL compares with its peers on the latest reported figures

  • COLL's LTM Mar 2026 cost of revenue of $313.15M is the highest of the 3 companies compared; the peer median is $83.55M.
  • Its year-over-year change of +11.4% is the highest of 3, against a peer median of +1.8%.
  • Cost of revenue amounts to 39.3% of revenue for COLL, versus a peer median of 32.9%.
COLL Competitors Peer median
Cost of Revenue for COLL and competitors
Company Period LTM YoY 3-year CAGR% of revenue
COLLCollegium Pharmaceutical, Inc.LTM Mar 2026$313.15M +11.4%+7.6%39.3%
PCRXPacira BioSciences, Inc.LTM Mar 2026$151.86M -3.5%-9.1%20.7%
SCLXScilex Holding CompanyLTM Mar 2026$15.25M +7.1%+12.1%45.0%
LTGOLatigo Biotherapeutics Inc.—— ———
Peer median (excluding COLL) $83.55M+1.8%+1.5%32.9%

Competitors are the stored peer set for COLL. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue276.87M463.93M566.77M631.45M780.57M
Cost of Revenue126.25M254.45M240.6M254.11M317.31M
Gross Profit150.62M209.49M326.17M377.34M463.26M
Gross Margin54.4%45.2%57.5%59.8%59.3%
Research & Development9.45M3.98M000
Selling, General & Admin118.96M172.19M159.21M182.98M276.17M
Operating Expenses132.99M176.17M159.21M207.45M276.17M
Depreciation & Amortization68.92M138.94M149.26M169.16M226.07M
EBITDA86.56M173.31M308.33M341.7M401.01M
EBITDA Margin31.3%37.4%54.4%54.1%51.4%
Operating Income17.63M33.32M166.96M169.9M187.08M
Operating Margin6.4%7.2%29.5%26.9%24.0%
Interest Income12K1.05M15.62M13.98M11.29M
Interest Expense21.01M63.21M83.34M73.97M82.31M
Other Income / Expenses(21M)(62.17M)(91.23M)(71.33M)(94.47M)
Income Before Tax(3.37M)(28.85M)75.73M98.57M92.62M
Pre-Tax Margin-1.2%-6.2%13.4%15.6%11.9%
Income Tax Expense(74.89M)(3.85M)27.58M29.38M29.75M
Net Income71.52M(25M)48.16M69.19M62.87M
Net Margin25.8%-5.4%8.5%11.0%8.1%
EPS (Basic)2.05(0.74)1.602.141.98
EPS (Diluted)1.86(0.74)1.291.861.73
Weighted Avg Shares34.94M33.83M33.74M32.27M31.71M
Weighted Avg Shares (Diluted)41.05M33.83M41.79M40.42M39.7M

Collegium Pharmaceutical, Inc.

NASDAQ:COLL

Intrinsic Alpha fair value

Locked

Current Price

$25.93

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.